
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GSK | NYSE | USD | Real-time | |
GSKl | BATS Europe | GBP | Delayed | |
GLAXF | OTC Markets | USD | Delayed | |
GSK | London | GBP | Real-time | |
GSKN | Mexico | MXN | Delayed | |
GS71 | Xetra | EUR | Delayed | |
GSK | TradeGate | EUR | Delayed | |
GSK | Frankfurt | EUR | Delayed | |
GSKy | Frankfurt | EUR | Delayed | |
GSK | Buenos Aires | ARS | Delayed |
GSK plc, formerly GlaxoSmithKline PLC is a global healthcare company. The Company is focused to improve the quality of human life by helping people. The Company operates through three core businesses: Pharmaceuticals, Vaccines and Consumer Healthcare. Its Pharmaceuticals business has a portfolio of established medicines in respiratory, human immunodeficiency viruses (HIV), immuno-inflammation and oncology. It also focuses on immunology, human genetics, and advanced technologies to deliver transformational new medicines for patients. The Company's research and development focuses on developing vaccines against infectious diseases that combine high medical needs and market potential. The Company's Consumer Healthcare business combines science and consumer insights to create everyday healthcare brands for oral health, pain relief, cold, flu and allergy, digestive health, and vitamins, minerals and supplements. It provides prescription medicines, vaccines, and consumer healthcare products.
Name | Age | Since | Title |
---|---|---|---|
Iain James Mackay | 59 | 2019 | CFO & Executive Director |
Emma N. Walmsley | 51 | 2011 | CEO & Director |
Jonathan Richard Symonds | 62 | 2019 | Non-Executive Chairman |
Vishal Sikka | - | 2022 | Independent Non-Executive Director |
Harry C. Dietz | 64 | 2022 | Independent Non-Executive Director |
Anne C. Beal | 60 | 2021 | Independent Non-Executive Director |
Jesse L. Goodman | 70 | 2016 | Independent Non-Executive Director |
Urs Rohner | 63 | 2015 | Independent Non-Executive Director |
Hal V. Barron | 59 | 2018 | Non-Executive Director |
Laurie H. Glimcher | 70 | 2017 | Independent Non-Executive Director |
Charles A. Bancroft | 62 | 2020 | Senior Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review